Results 81 to 90 of about 3,795,370 (153)
Essential medicines management during emergencies in Pakistan [PDF]
This paper illustrates the experiences of essential medicine management in providing cure and care to victims of Pakistan\u27s 2005 earthquake in a safe, rational and effective mode.
Bile, K.M. +6 more
core +1 more source
China and India as Suppliers of Affordable Medicines to Developing Countries [PDF]
As countries reform their patent laws to be in compliance with the Trade Related Intellectual Property Rights Agreement, an important question is how increased patent protection will affect drug prices in low-income countries.
Tamara Hafner, David Popp
core
The availability and affordability of essential medicines and other health products are critical to building resilient health systems and achieving Universal Health Coverage (UHC).
Maria-Belen Tarrafeta-Sayas +10 more
doaj +1 more source
How the MDGs gave up on measuring access to medicines
Dzintars Gotham +2 more
doaj +1 more source
Background: Investigating the causes and impact of essential medicines and supplies shortages in the supply chain of the MOH in Saudi Arabia could be the initial step in setting innovative strategies for mitigating this issue.
Balfaqih, Hasan
core
Essential Medicines in a High Income Country: Essential to Whom?
ObjectiveTo explore the perspectives of a diverse group of stakeholders engaged in medicines decision making around what constitutes an "essential" medicine, and how the Essential Medicines List (EML) concept functions in a high income country context ...
World Hospital Pharmacy Research Consortium (WHoPReC) +12 more
core +1 more source
The selection and use of essential medicines.
This report presents the recommendations of the WHO Expert Committee responsible for updating the WHO Model List of Essential Medicines. The first part contains a review of the report of the meeting of the Expert Subcommittee on the Selection and Use of ...
Cheraghali, AM +26 more
core
To be or not to be exclusive: the sutezolid story
Jane Andrews
doaj +1 more source
Affordable innovation: future directions in pharmaceutical policy
Suzanne R Hill
doaj +1 more source

